Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |